In Vivo AAV-SB-CRISPR Screens of Tumor-Infiltrating Primary NK Cells Identify Genetic Checkpoints of CAR-NK Therapy
AAV-SB-CRISPR Screening Identifies Genetic Checkpoints in Tumor-Infiltrating Primary Natural Killer Cells for CAR-NK Therapy With the rapid advancement of biotechnology and gene editing technologies, increasing attention is being paid to enhancing the clinical potential of natural killer (NK) cells in cancer therapy. Despite their potential in clin...